Cipla looks to ensure consistent drug supplies, as costs increase due to West Asia war, says MD & Global CEO
Cipla is working to ensure consistent drug supplies, even as freight and fuel costs, for example, increase due to a prolonged war in West Asia, a top official with the drugmaker said, after it announced its financial performance for the fourth quarter and year ended March 31, 2026. The company's net profit at ₹555 crore for the quarter under review…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
